Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin l

1. Citores, L.
2. Miguel Ferreras, J.
3. Muñoz, R.
4. Benı́tez, J.
5. Jiménez, P.
6. Girbés, T.